VIR files Form 144 to sell 88,000 pre-IPO shares

VIR filed a Form 144 notice to sell 88,000 pre-IPO common shares.

Rhea-AI Filing Summary

VIR filed a Form 144 notice to sell 88,000 pre-IPO common shares. The filing lists the securities to be sold as 88,000 Pre-IPO Shares with an original date of 01/17/2017. The excerpt also shows prior 10b5-1 sales by Vicki Lee Sato: 22,000 shares on 01/02/2026, 22,000 shares on 02/02/2026, and 42,377 shares on 02/24/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VIR's Form 144 disclose about the shares being offered?

The filing discloses an intended sale of 88,000 Pre-IPO common shares dated 01/17/2017. This is the registered quantity listed under “Securities To Be Sold” in the excerpt and is presented as pre-IPO shares.

Who recorded recent open-market sales in the excerpt for VIR?

The excerpt lists 10b5-1 sales by Vicki Lee Sato, including 22,000 shares on 01/02/2026, 22,000 shares on 02/02/2026, and 42,377 shares on 02/24/2026.

Are proceeds or recipients of the Form 144 sales specified for VIR?

The excerpt shows sale proceeds for the 10b5-1 transactions (for example, $413,366.45 for 02/24/2026), but it does not state who receives proceeds for the intended 88,000 pre-IPO share sale in the provided text.

Does the Form 144 excerpt state the trading venue for VIR shares?

Yes; the securities line in the excerpt references NASDAQ as the market. The filing ties the listed securities to NASDAQ in the Securities Information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001197020
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VIR BIOTECHNOLOGY INC
SEC File Number	001-39083
Address of Issuer	1800 Owens Street Suite 900 San Francisco CALIFORNIA 94158
Phone	4159064324
Name of Person for Whose Account the Securities are To Be Sold	VICKI LEE SATO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	88000	799920.00	139517278	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/17/2017	Pre-IPO Shares	Issuer			88000	01/17/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for VICKI LEE SATO 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/24/2026	42377	413366.45
10b5-1 Sales for VICKI LEE SATO 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/02/2026	22000	169670.60
10b5-1 Sales for VICKI LEE SATO 1800 Owens Street Suite 900 San Francisco CA 94158	Common	01/02/2026	22000	130383.00

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Vicki Lee Sato
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)